| Literature DB >> 19384458 |
S M M de Castro1, J T Houwert, S M Lagarde, J B Reitsma, O R C Busch, T M van Gulik, H Obertop, D J Gouma.
Abstract
BACKGROUND: Comparison of operative morbidity rates after pancreatoduodenectomy between units may be misleading because it does not take into account the physiological variable of the condition of the patients. The aim of the present study was to evaluate the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM) for pancreatoduodenectomy patients and to look for risk factors associated with morbidity in a high-volume center.Entities:
Mesh:
Year: 2009 PMID: 19384458 PMCID: PMC2691933 DOI: 10.1007/s00268-009-0037-z
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Physiological and operative severity assessment for the POSSUM system
| Score | 1 | 2 | 4 | 8 |
|---|---|---|---|---|
| Age (years) | ≤60 | 61–70 | ≥71 | NA |
| Cardiac signs | Normal | Cardiac drugs or steroids | Edema; warfarin | Raised JVP |
| CXR | Normal | NA | Borderline cardiomegaly | Cardiomegaly |
| Respiratory signs | Normal | SOB exertion | SOB stairs | SOB rest |
| CXR | Normal | Mild COAD | Moderate COAD | Any other change |
| Systolic BP (mm Hg) | 110–130 | 131–170 | ≥171 | ≤89 |
| Pulse (Beats/min) | 50–80 | 81–100 | 101–120 | ≥121 |
| Coma score | 15 | 12–14 | 9–11 | ≤8 |
| Urea nitrogen (mmol/l) | <7.5 | 7.6–10 | 10.1–15 | ≥15.1 |
| Na (mEq/l) | ≥136 | 131–135 | 126–130 | ≤125 |
| K (mEq/l) | 3.5–5 | 3.2–3.4 | 2.9–3.1 | ≤2.8 |
| Hb (g/dl) | 13–16 | 11.5–12.9 | 10–11.4 | ≤9.9 |
| WCC × 1012/l | 4–10 | 10.1–20 | ≥20.1 | NA |
| ECG | Normal | NA | AF (60–90) | Any other change |
| Operative magnitude | Minor | Intermediate | Major | Major+ |
| No. of operations within 30 days | 1 | NA | 2 | >2 |
| Blood loss per operation(ml) | <100 | 101–500 | 501–999 | >1,000 |
| Peritoneal contamination | No | Serous | Local pus | Free bowel content, pus or blood |
| Presence of malignancy | No | Primary cancer only | Node metastases | Distant metastases |
| Timing of operation | Elective | Emergency resuscitation possible, operation <24 h | Emergency immediate, operation <2 h | |
POSSUM formula: Ln R/1 − R = −7.04 + (0.13 × physiological score) + (0.16 × operative severity score)
In some variables, signs may be assessed clinically and/or by changes in results on chest X-ray film (CXR)
NA not applicable, JVP jugular venous pressure, SOB shortness of breath, COAD chronic obstructive airway disease, BP blood pressure, Na sodium, K potassium, Hb hemoglobin, WCC white blood cell count, ECG electrocardiogram, AF atrial fibrillation
Characteristics of patients undergoing surgery for periampullary neoplasms
| ( | |
|---|---|
| Gender | |
| Male | 359 (55) |
| Female | 293 (45) |
| Median age (range) | 69 (23–91) |
| Procedure | |
| Pyloric preserving pancreatoduodenectomy | 548 (84.1) |
| Kausch-Whipple pancreatoduodenectomy | 104 (16) |
| Number of patients who underwent vascular resection | 67 (10) |
| Pathology | |
| Pancreatic adenocarcinoma | 233 (35.7) |
| Ampullary adenocarcinoma | 157 (24.1) |
| Distal common bile duct adenocarcinoma | 91 (14) |
| Pancreatitis | 72 (11) |
| Other malignant | 46 (7) |
| Other benign | 26 (4) |
| Duodenum adenocarcinoma | 14 (2) |
| Tubulovilleus adenoma | 13 (2) |
| Overall complications | 332 (50.9) |
| Delayed gastric empting | 139 (21.3) |
| Intra-abdominal abscess | 98 (15) |
| Pulmonary | 72 (11) |
| Pancreaticojejunostomy leakage | 59 (9) |
| Wound infection | 46 (7) |
| Hemorrhage | 46 (7) |
| Urinary tract infections and renal | 45 (7) |
| Cardiac | 39 (6) |
| Hepaticojejunostomy leakage | 20 (3) |
| Miscellaneous | 34 (5) |
| Number of patients who underwent a relaparotomy | 65 (10) |
| Median intensive care stay in days (range) | 1 (0–84) |
| Median overall postoperative hospital stay in days (range) | 15 (6–222) |
| Hospital stay for patients | |
| With complications | 22 (6–222) |
| Without complications | 13 (6–55) |
| Mortality | 9 (1.4) |
| Macroscopically radical resection in case of malignancy | 336/502 (66.9) |
Numbers between parentheses are percentages unless indicated otherwise
Fig. 1Calibration curve of surgical morbidity (symbols with 95% confidence interval) showing significant deviation from the diagonal line, which represents a perfect predictive ability when the observed to expected ratio is 1.00. The bars represent the number of patients in each risk group. (O:P ratio = 0.88, χ2 = 30.24, 8 degrees of freedom, P < 0.001, indicating significantly poor fit)
Univariate and multivariate analysis of variables found to be significantly associated with morbidity
| Patients ( | No. of complications | Univariate unadjusted odds ratio (95% CI) | Multivariate adjusted odds ratio (95% CI) | |
|---|---|---|---|---|
| Age (per 10-year increment) | 1.18 (1.02–1.37) | |||
| Sex | ||||
| Female | 293 | 132 (45.1) | 1.00 | |
| Male | 359 | 199 (55.4) | 1.51 (1.06–2.15) | |
| BMI (per point increment) | 1.05 (1.01–1.10) | |||
| Hypertension | ||||
| No | 628 | 305 (48.6) | 1.00 | |
| Yes | 24 | 15 (63) | 1.63 (1.04–2.55) | |
| Cardiac history | ||||
| No | 616 | 296 (48.1) | 1.00 | |
| Yes | 36 | 22 (61) | 1.74 (1.13–2.70) | |
| Pulmonary history | ||||
| No | 552 | 267 (48.4) | 1.00 | |
| Yes | 100 | 68 (68) | 2.29 (1.32–3.98) | 2.05 (1.15–3.67) |
| Blood loss (per 100 ml increment) | 1.02 (1.00–1.04) | |||
| Type of tumor | ||||
| Pancreatic adenocarcinoma | 233 | 107 (46) | 1.00 | |
| Ampulla of Vater adenocarcinoma | 157 | 93 (59) | 1.72 (1.08–2.73) | 1.73 (1.07–2.80) |
| Distal bile duct adenocarcarcinoma | 91 | 41 (45) | 0.96 (0.55–1.68) | |
| Pancreatitis | 72 | 34 (47) | 1.05 (0.57–1.94) | |
| Duodenum adenocarcinoma | 14 | 9 (64) | 2.36 (0.69–8.10) | |
| Other malignancy | 46 | 22 (48) | 1.06 (0.53–2.14) | |
| Other benign | 26 | 15 (58) | 1.53 (0.64–3.67) | |
| Tubulovillus adenoma | 13 | 10 (77) | 4.71 (0.97–22.81) | |
Numbers in parentheses are percentages unless indicated otherwise
Factors analyzed in univariate analysis that were not significant include: diabetes, American Society of Anesthesiologists classification, surgeon’s experience, classical Whipple or pylorus-preserving pancreatoduodenectomy, transsection with surgical knife or linear stapler, use of multicomponent fibrin sealant, single or Roux-en-Y jejunal loop, one- or two layer anastomosis, drainage of pancreatic or biliary duct, packed cells transfused, use of octreotide and microscopic completeness of pancreatic resection plane in case of malignancy. Pancreatic texture was not scored regularly and was therefore omitted from the analysis